Thames Valley Chamber of Commerce (TVCC) hosted its latest Thames Valley’s Health and Life Sciences Working Group to, once again, a full house at Green Park Conference Centre.
With sponsors Blake Morgan LLP, Green Park and James Cowper Kreston, the session was themed around the topic of funding of the NHS, life sciences and health care, from the earliest stages of drug and medical device development to the funding of innovation take up within the health services and the effective operations of the health system, including public-private partnership opportunities.
Chaired by Sue Staunton, Partner and Head of Life Sciences at James Cowper Kreston, the Chamber welcomed speakers Dr Mamta Bajre, Head of Health Economics & Methodology, Health Innovation Network Oxford & Thames Valley and Jim Wilkinson, Chair, Oxford Seed Fund and former Chief Financial Officer, Oxford Science Enterprises.
The panel session on NHS/Health Sector funding and finance features speakers Adrian Hill, former Director of Health Tech, Innovate UK, UKRI, Kiran Gulati, Director of Market Development, New England Biolabs and Alison Patten-Hall, Partner, Blake Morgan LLP and Raja Rajaram, Head of Global Medical Strategy, Seqirus.
The Chamber always looks to showcase its working group members, and this time was no different. RSSL’s Jacinta George spoke about the power of partnership and NFX UK; ICON Group’s Kevin Sullivan spoke about their new Thames Valley facility and Robert Bowen, ICB provided an introduction to the new ICB and its priorities.
The final update focused on women’s health. Anna Boniface, Advanced Critical Care Practitioner at Royal Berkshire NHS Foundation Trust outlined her PhD Project on how does critical illness influence women’s experiences of the menstrual system, menopause, and their engagement with healthcare services. Anna has a call to arms for help in her research.
TVCC are proud to continue to host the Thames Valley’s only region-wide, curated, Health and Life Sciences working group. This industry-led group serves as a vital platform for collaboration, convening global corporates, innovative SMEs, academic institutions, and educational establishments (including LSIP partners), NHS trusts, government stakeholders, professional bodies, and pre-eminent thought leaders.
The 2027 schedule is set and the programme of topics are being shaped to include healthcare procurement, prevention and population health, AI in healthcare, women’s health, international trade and global supply chains and pharma manufacturing.
Future dates for the Working Group are –
- Thursday 28th January 2027
- Thursday 17th June 2027
- Thursday 4th November 2027
Find out more about this invitation only working group.
